2012 - Member of the National Academy of Medicine (NAM)
His main research concerns Prostate cancer, Internal medicine, Prostate-specific antigen, Gynecology and Prostate. The Prostate cancer study combines topics in areas such as Randomized controlled trial, Surgery and Urology. The various areas that Fritz H. Schröder examines in his Internal medicine study include Endocrinology and Oncology.
His research in Prostate-specific antigen intersects with topics in Prostate biopsy, Nephrology and Antiandrogen. In Gynecology, he works on issues like Quality of life, which are connected to Anxiety. His work deals with themes such as Biopsy, Pathology and Metastasis, which intersect with Prostate.
Prostate cancer, Internal medicine, Oncology, Prostate and Prostate-specific antigen are his primary areas of study. The concepts of his Prostate cancer study are interwoven with issues in Gynecology, Randomized controlled trial and Urology. His Internal medicine research incorporates themes from Endocrinology and Surgery.
His work carried out in the field of Oncology brings together such families of science as Stage, Clinical trial, PCA3 and Endocrine system. His Prostate study incorporates themes from Adenocarcinoma and Biopsy, Pathology. His studies deal with areas such as Prostate biopsy, Nephrology and Cancer screening as well as Prostate-specific antigen.
Fritz H. Schröder mainly investigates Prostate cancer, Internal medicine, Oncology, Prostate-specific antigen and Gynecology. Fritz H. Schröder interconnects Prostate, Randomized controlled trial and Urology in the investigation of issues within Prostate cancer. His research brings together the fields of Surgery and Internal medicine.
His Oncology research includes themes of Androgen deprivation therapy, Clinical trial and Metastasis. His Prostate-specific antigen study combines topics from a wide range of disciplines, such as Prostate biopsy, Cohort study, Cancer screening and PCA3. He usually deals with Gynecology and limits it to topics linked to Confidence interval and Cause of death.
His primary areas of study are Prostate cancer, Internal medicine, Prostate-specific antigen, Oncology and Gynecology. His Prostate cancer research integrates issues from Biopsy, Prostate and Randomized controlled trial. His Internal medicine course of study focuses on Surgery and Hazard ratio and Watchful waiting.
His Prostate-specific antigen research is multidisciplinary, relying on both Psychiatry, Cohort study and Urology. His biological study spans a wide range of topics, including Prostatectomy, Metastasis, Clinical trial and Radiation therapy. His Gynecology research incorporates elements of Stage, Predictive value of tests, Cumulative incidence and Mass screening.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto.
The New England Journal of Medicine (2009)
Prostate-Cancer Mortality at 11 Years of Follow-up
Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto.
The New England Journal of Medicine (2012)
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
Fritz H Schröder;Jonas Hugosson;Monique J Roobol;Teuvo L J Tammela.
The Lancet (2014)
Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.
Gerrit Draisma;Rob Boer;Suzie J. Otto;Ingrid W. van der Cruijsen.
Journal of the National Cancer Institute (2003)
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials
O Dalesio;H van Tinteren;M Clarke;R Peto.
The Lancet (2000)
The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer
Laurence Klotz;Laurent Boccon-Gibod;Neal D. Shore;Cal Andreou.
BJUI (2008)
Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies
Morgan R. Pokorny;Maarten de Rooij;Earl Duncan;Fritz H. Schröder.
European Urology (2014)
Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
Meelan Bul;Xiaoye Zhu;Riccardo Valdagni;Tom Pickles.
European Urology (2013)
The TNM classification of prostate cancer
F H Schröder;P Hermanek;L Denis;W R Fair.
The Prostate (1992)
A Prospective European Organization for Research and Treatment of Cancer Genitourinary Group Randomized Trial Comparing Transurethral Resection Followed by a Single Intravesical Instillation of Epirubicin or Water in Single Stage Ta, T1 Papillary Carcinoma of the Bladder
Willem Oosterlinck;Karl Heinz Kurth;Fritz Schröder;Jozef Bultinck.
The Journal of Urology (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Erasmus MC
Erasmus University Rotterdam
Erasmus University Rotterdam
Memorial Sloan Kettering Cancer Center
University of Amsterdam
Leiden University
Tampere University
Tampere University
Erasmus University Rotterdam
European Organisation for Research and Treatment of Cancer
Washington State University
Institute of Applied Physics and Computational Mathematics
Carnegie Mellon University
Chinese Academy of Sciences
Ministry of Agriculture, Livestock, and Food Supply
University of Picardie Jules Verne
Baylor University
United States Naval Research Laboratory
Arizona State University
University of Oxford
University of British Columbia
Johns Hopkins University School of Medicine
Brock University
University of Pisa
University of California, San Diego
Aix-Marseille University